comparemela.com

Latest Breaking News On - Catalys pacific - Page 1 : comparemela.com

Catalys Pacific LLC Makes New Investment in Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT)

Catalys Pacific LLC purchased a new position in shares of Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT – Free Report) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 721,962 shares of the company’s stock, valued at approximately $6,592,000. Phathom Pharmaceuticals accounts for about 6.2% of […]

United-states
Wellington
New-zealand-general
New-zealand
Canada
Terrie-curran
Stifel-nicolaus
Molly-henderson
Catalys-pacific
News-ratings-for-phathom-pharmaceuticals-daily
Phathom-pharmaceuticals-stock-performance
Quarter-for-phathom-pharmaceuticals

Mineralys Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update

Mineralys Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Radnor
Pennsylvania
United-states
Jon-congleton
Tom-weible
Tanabe-pharma
Catalys-pacific
Exchange-commission
Nasdaq
Elixir-health-public-relations
Drug-administration
Mineralys-therapeutics-inc

HilleVax, Inc. (NASDAQ:HLVX) Director Aditya Kohli Sells 723 Shares

HilleVax, Inc. (NASDAQ:HLVX) Director Aditya Kohli Sells 723 Shares
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United-states
Switzerland
Swiss
Aditya-kohli
Franklin-resources-inc
Hillevax-inc
Securities-exchange-commission
Nasdaq
Swiss-national-bank
Catalys-pacific
Hillevax-company-profile
Mokshaco-inc

HilleVax (NASDAQ:HLVX) Shares Gap Up to $12.02

Shares of HilleVax, Inc. (NASDAQ:HLVX – Get Free Report) gapped up prior to trading on Friday . The stock had previously closed at $12.02, but opened at $12.58. HilleVax shares last traded at $11.99, with a volume of 1,768 shares. Analyst Ratings Changes Separately, HC Wainwright reiterated a “buy” rating and issued a $28.00 price […]

Robert-hershberg
Aditya-kohli
Catalys-pacific
Acuta-capital-partners
Mokshaco-inc
Nasdaq
Hillevax-inc
Deerfield-management-companylp-series
Get-free-report
Director-aditya-kohli
Capital-partners
Adage-capital-partners

Renalys Pharma Submits an IND Application for a Phase III Clinical Trial of sparsentan for IgA Nephropathy in Japan

Renalys Pharma Submits an IND Application for a Phase III Clinical Trial of sparsentan for IgA Nephropathy in Japan
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

Laos
Brunei
Singapore
Chuo-ku
Tokyo
Japan
Taiwan
Malaysia
Thailand
Indonesia
Vietnam
Republic-of
© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.